Literature DB >> 3266118

Interleukin 2 receptor expression by macrophages in inflammatory bowel disease.

Y R Mahida1, S Patel, K Wu, D P Jewell.   

Abstract

The expression of interleukin 2 receptor by macrophages from normal and inflamed terminal ileum and colon has been studied by using two monoclonal antibodies. In tissue sections from normal ileum and colon, scattered positive lymphocytes and only occasional weakly positive macrophages were seen. In ileal and colonic Crohn's disease or ulcerative colitis many positive macrophages and lymphocytes were seen in the lamina propria. These findings were confirmed by staining cytospin preparations of isolated intestinal mononuclear cells. The isolated macrophages were able to phagocytose opsonized zymosan and the majority were able to undergo a respiratory burst when triggered with opsonized zymosan or phorbol myristate acetate (PMA), suggesting that they were activated. Stimulation with interferon-gamma or lipopolysaccharide did not increase the number of macrophages staining with the antibodies to the interleukin 2 receptor. Therefore we postulate that a large majority of the macrophages expressing interleukin 2 receptor in inflammatory bowel disease are a recently recruited population of cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3266118      PMCID: PMC1542037     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.

Authors:  F Pallone; S Fais; O Squarcia; L Biancone; P Pozzilli; M Boirivant
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

2.  The structure of the colonic mucosa. The epithelium and subepithelial reticulohistiocytic complex.

Authors:  W L Donnellan
Journal:  Gastroenterology       Date:  1965-11       Impact factor: 22.682

3.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

4.  Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques.

Authors:  W S Selby; G Janossy; M Bofill; D P Jewell
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

5.  Receptors for maleylated proteins regulate secretion of neutral proteases by murine macrophages.

Authors:  W J Johnson; S V Pizzo; M J Imber; D O Adams
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

6.  Macrophage turnover in Crohn's disease and ulcerative colitis.

Authors:  G Meuret; A Bitzi; B Hammer
Journal:  Gastroenterology       Date:  1978-03       Impact factor: 22.682

7.  Monocytes in inflammatory bowel disease: phagocytosis and intracellular killing.

Authors:  A S Mee; M Szawatakowski; D P Jewell
Journal:  J Clin Pathol       Date:  1980-10       Impact factor: 3.411

8.  Chronic inflammatory bowel disease--increased plasminogen activator secretion by mononuclear phagocytes.

Authors:  W F Doe; B Dorsman
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

9.  Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis.

Authors:  W S Selby; L W Poulter; S Hobbs; D P Jewell; G Janossy
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  30 in total

1.  Evidence against an autoimmune aetiology for inflammatory bowel diseases.

Authors:  F Pallone; S Fais; M R Capobianchi
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.

Authors:  J E Crabtree; L D Juby; R V Heatley; A J Lobo; D W Bullimore; A T Axon
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

3.  Macrophage activity in inflammatory bowel disease.

Authors:  Y R Mahida; D P Jewell
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

4.  Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease.

Authors:  Y R Mahida; A Gallagher; L Kurlak; C J Hawkey
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

Review 5.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

6.  Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis.

Authors:  M Y Choy; J A Walker-Smith; C B Williams; T T MacDonald
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

7.  Interleukin-2 receptor expression.

Authors:  Y R Mahida
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

8.  Interferon-alpha (IFN-alpha) production by human intestinal mononuclear cells. Response to virus in control subjects and in Crohn's disease.

Authors:  M R Capobianchi; S Fais; F Mercuri; M Boirivant; F Dianzani; F Pallone
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

9.  Lymphocyte and macrophage subpopulations in pelvic ileal pouches.

Authors:  H J de Silva; M Jones; C Prince; M Kettlewell; N J Mortensen; D P Jewell
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

10.  5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease.

Authors:  Y R Mahida; C E Lamming; A Gallagher; A B Hawthorne; C J Hawkey
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.